High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis
Richard A. Nash(Colorado Blood Cancer Institute), George H. Kraft(Patara Pharma (United States)), Kate Ryan(Manchester Royal Infirmary), Keith M. Sullivan(Duke Medical Center), John R. Corboy(University of Colorado Denver), C.F. LeMaistre(City Of Hope National Medical Center), James D. Bowen(Swedish Medical Center), Jinan Al-Omaishi(City Of Hope National Medical Center), John F. DiPersio(Washington University in St. Louis), Steven Z. Pavletic(National Institutes of Health), Jan Storek(University of Washington), Rainer Storb(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Joseph R. Zunt(University of Washington), Leona Holmberg(University of Washington), Peter A. McSweeney(Mesoblast (United States)), Harry Openshaw(City Of Hope National Medical Center), Kenneth R. Maravilla(University of Washington), Man-soo Park(City Of Hope National Medical Center), Julie Sunderhaus(City Of Hope National Medical Center), Theodore A. Gooley(Leipzig University), George E. Georges(Northwestern University)
Cited by 221
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Chronic graft-versus-host syndrome in man
|The American Journal of Medicine|1980|2.4k